The apparent success — and now almost ever-present ubiquity — of GLP-1 receptor agonists in weight loss has led to research, and possible uses, far beyond its initial indications in diabetes, ...

Risk factors contributing to LBP worldwide have shifted between 1990 and 2021, with high BMI increasingly impacting years lived with disability due to LBP.